We regularly host Expert Talks for our consortium and internal network. These talks are given by invited speakers who are leading experts in their respective fields. The Expert Talk Series cover a range of topics relevant to CD research aimed at enhancing current understanding of the condition and contribute towards the development of effective therapies.
- Dr. Andrew Anzalone, MD, PHD (Co-Founder and Head of Prime Editing Platform, Prime Medicine)
Prime Medicine, Massachusetts, USA- Title: Prime Editing Technology
Date: 8/10/2024
- Professor Donald Ingber, MD, PHD (Founding Director, Wyss Institute)
Harvard University, Massachusetts, USA- Title: Human Organ-on-a-chip technology & AI drug discovery approach
Date: 18/09/2024
- Professor Uğur Şahin, MD, PHD (Co-Founder and CEO, BioNTech)
BioNTech, Mainz, Germany- Title: mRNA Therapies – Therapeutic strategies beyond Vaccines
Date: 5/09/2023
- Professor Julian Sale, MD, PhD, MRCP (Programme Leader, Division of Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology)
University of Cambridge, Cambridge, UK- Title: Principles of gene regulation and its potential modulation in citrin deficiency
Date: 16/05/2023
- Professor Marc Hellerstein, MD, PhD (Robert C. and Veronica Atkins Chair in Metabolic Nutrition and Professor of Human Nutrition, Department of Nutritional Sciences and Toxicology)
University of California at Berkeley, California, USA- Title: Mass Isotopomer Distribution Analysis (MIDA): The “Equation for Polymerization Biosynthesis”
Date: 17/11/2022
- Professor Pieter Cullis, PhD, FRSC, FNAI (USA), OC (Director of Nanomedicines Research Group and Professor, Department of Biochemistry and Molecular Biology)
University of British Columbia, Vancouver, Canada- Title: From Basic Research to COVID-19 mRNA Vaccines: The Lipid Nanoparticle Story
Date: 4/10/2022
Speakers (by order of presentations):
- Professor Markus Grompe, MD (Ray Hickey Professor and Director of the Papé Family Pediatric Research Institute and Professor of Pediatrics)
Oregon Health and Science University, Oregon, USA- Title: Metabolic Causes and Consequences of Nonalcoholic Fatty Liver Disease and New Therapies Targeting the Mitochondria
- Professor Simon Waddington, PhD (Professor of Gene Therapy, EGA Institute for Women’s Health)
University College London, London, UK- Title: Gene therapy – spoilt for choice
- Professor Charles Venditti, MD, PhD (Senior Investigator, National Human Genome Research Institute and the Director of the Organic Acid Research Section)
National Institute of Health, Maryland, USA- Title: Genomic Therapies for MMA: Lessons from Patients and Mice
Date: 26/04/2022
- Professor Stephen Strom, PhD (Professor Emeritus of Cell Transplantation Research, Department of Laboratory Medicine)
Karolinska Institute, Stockholm, Sweden- Title: Use of liver-humanized mice and gene editing technology to investigate the correction of a urea cycle defect in human hepatocytes.
Date: 28/03/2022
Speakers (by order of presentations):
- Professor Gerald L. Shulman MD, PhD, MACP, MACE, FRCP (George R. Cowgill Professor of Medicine and Cellular & Molecular Physiology and Co-Director of Yale Diabetes Research Center)
Yale School of Medicine, Connecticut, USA- Title: Metabolic Causes and Consequences of Nonalcoholic Fatty Liver Disease and New Therapies Targeting the Mitochondria
- Professor Hannele Yki-Järvinen MD, PhD, FRCP (Professor of Medicine for the Department of Medicine)
University of Helsinki
School of Medicine, Helsinki, Finland- Title: NAFLD and Citrin deficiency associated liver disease
Date: 21/03/2022
Speakers (by order of presentations):
- Professor Takanori Takebe, MD, PhD (Director of Center for Stem Cell & Organoid Medicine (CuSTOM); Professor at the Advanced Medical and Dental
Engineering Research Division, Integrated Research Organization)
Cincinnati Children’s Hospital Medical Center, Cincinnati, USA
Tokyo Medical and Dental University, Japan- Title: Pursuing potential of Organoid Medicine
- Professor Meritxell Huch, PhD (Lise Meitner Max Planck Research Group Leader)
Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany- Title: Tissue-derived liver organoids enable the identification of basic principles of liver biology both in health and disease
Date: 21/11/2021
